John Kilhefner

John Kilhefner

Senior Managing Editor, Lango Franchise

John Kilhefner is Senior Managing Editor of the Luke Lango franchise, which includes Hypergrowth Investing, Innovation Investor, Crypto Investor Network, and more.
Kilhefner has contributed to media such as Benzinga, The Hill, Tip Ranks, Unwinnable, The Arcade Review, Five Out of Ten magazine, and ZAM. He has appeared in U.S. News and World Report, Kotaku, USA Today, and Game Developer.
He now runs his own creative agency focused on tech and cybersecurity, called Skellator, LLC.
Learn more here

Recent Articles

Apple Inc. (AAPL) Awarded Video-Shutdown Patent

By John Kilhefner, Senior Managing Editor, Lango Franchise

Apple (AAPL) was awarded a patent to remotely shutdown your phone in video-sensitive venues. But there could be other implications.

Tesaro Inc (TSRO) Stock Soars 100% on Ovarian Cancer Drug Results

By John Kilhefner, Senior Managing Editor, Lango Franchise

Tesaro Inc (NASDAQ:TSRO) is flying high on encouraging results from its ovarian cancer drug, niraparib, but it's still not FDA-approved.

Why Gilead Sciences, Inc. (GILD), Bank of America Corp (BAC) and Facebook Inc (FB) Are 3 of Today’s Best Stocks

By John Kilhefner, Senior Managing Editor, Lango Franchise

The markets fared their best since the "Brexit" vote, but GILD, BAC and FB stood out the most as Tuesday's best stocks.

GILD Stock: FDA Greenlights Gilead Sciences, Inc. Hep-C Drug Epclusa

By John Kilhefner, Senior Managing Editor, Lango Franchise

Gilead Sciences (GILD) stock is up big Tuesday after the FDA granted its drug, Epclusa, approval for use in chronic HCV patients.

Carnival Corp (CCL) Kills on Earnings, Announces $1B Stock Buyback

By John Kilhefner, Senior Managing Editor, Lango Franchise

Carnival (NYSE:CCL) announced better-than-expected earnings for Q2, while a $1B buyback program competes with low-ball Q3 numbers.

Load More